SETD2 and nonpapillary renal cell carcinoma: Loss of SETD2, therefore, weakens MMR surveillance, contributing to mutational burden even without classical microsatellite instability—an effect particularly relevant in ccRCC, where 3p loss and SETD2 mutation co-occur [68].